-
Rybakina stuns Swiatek to reach Australian Open semi-finals
-
US ouster of Maduro nightmare scenario for Kim: N. Korean ex-diplomat
-
Svitolina credits mental health break for reaching Melbourne semis
-
Japan's Olympic ice icons inspire new skating generation
-
Safe nowhere: massacre at Mexico football field sows despair
-
North Korea to soon unveil 'next-stage' nuclear plans, Kim says
-
French ex-senator found guilty of drugging lawmaker
-
US Fed set to pause rate cuts as it defies Trump pressure
-
Sleeping with one eye open: Venezuelans reel from US strikes
-
Venezuela's acting president says US unfreezing sanctioned funds
-
KPop Demon Hunters star to open Women's Asian Cup
-
Trump warns of 'bad things' if Republicans lose midterms
-
Russian strikes in Ukraine kill 12, target passenger train
-
With Maduro gone, Venezuelan opposition figure gets back to work
-
Celebrities call for action against US immigration raids
-
Rubio to warn Venezuela leader of Maduro's fate if defiant
-
Denver QB Nix 'predisposed' to ankle injury says coach
-
Lula, Macron push for stronger UN to face Trump 'Board of Peace'
-
Prass stunner helps Hoffenheim go third, Leipzig held at Pauli
-
Swiss Meillard wins final giant slalom before Olympics
-
CERN chief upbeat on funding for new particle collider
-
Trump warns US to end support for Iraq if Maliki returns
-
Judge reopens sexual assault case against goth rocker Marilyn Manson
-
South Korea's ex-first lady to learn verdict in corruption case
-
Rosenior dismisses Chelsea exit for 'untouchable' Palmer
-
Markram powers South Africa to win over West Indies
-
Vladimir Padrino: Venezuela's military power broker
-
Amazon closing Fresh and Go stores in Whole Foods push
-
Koepka nervous about game and fans in PGA Tour return
-
Trump's Iowa trip on economy overshadowed by immigration row
-
Dortmund coach says Inter Milan are improved under Chivu
-
US border chief in Minneapolis as Trump tries to calm crisis
-
What to know about America's colossal winter storm
-
Iran warns against 'instability' after US strike group arrives
-
GM reports quarterly loss but boosts shareholder returns
-
US banks fight crypto's push into Main Street
-
NFL Bills make offensive coordinator Brady new head coach
-
TikTok settles hours before landmark social media addiction trial
-
Newcastle braced for 'ultimate test' against PSG after storm disruption
-
Brook blitz ends Sri Lanka's unbeaten home run, England clinch series
-
LVMH 2025 net profit drops 13% to 10.9 bn euros
-
Philip Glass pulls Kennedy Center premiere after Trump takeover
-
Slot says Liverpool must fix 'very bad cocktail'
-
How to assess microplastics in our bodies? Scientists have a plan
-
US sued over deadly missile strikes on alleged drug boats
-
Trump ally Asfura sworn in as Honduras president
-
US border enforcer set to leave Minneapolis as Trump tries to calm crisis
-
US consumer confidence drops to lowest level since 2014
-
Teens underwhelmed by France's social media ban
-
Trump ally Nasry Asfura sworn in as Honduras president
Ghostwriters, polo shirts, and the fall of a landmark pesticide study
A flagship study that declared the weedkiller Roundup posed no serious health risks has been retracted with little fanfare, ending a 25-year saga that exposed how corporate interests can distort scientific research and influence government decision-making.
Published in Regulatory Toxicology and Pharmacology in 2000, the paper ranks in the top 0.1 percent of citations among studies on glyphosate -- the key ingredient in Roundup, owned by agri-giant Monsanto and at the center of cancer lawsuits worth billions of dollars.
In his retraction note last week, the journal's editor-in-chief, Martin van den Berg, cited a litany of serious flaws from failing to include carcinogenicity studies available at the time to undisclosed contributions by Monsanto employees and even questions around financial compensation.
Elsevier, the journal's Dutch publisher, told AFP in a statement that it upholds the "highest standards of rigor and ethics" and that "as soon as the current editor became aware of concerns regarding this paper a matter of months ago, due process began."
But it did not address the fact that concerns date back to 2002, when critics wrote to Elsevier about "conflicts of interest, lack of transparency, and the absence of editorial independence" at the journal, including specific worries about Monsanto.
The matter exploded into public view in 2017, when internal corporate documents released during litigation showed one of Monsanto's own scientists admitting to "ghostwriting."
Harvard University science historian Naomi Oreskes, who co-authored a paper this September detailing the extent of the "fraud" in the 2000 study, told AFP that while she was "very gratified" at the "long overdue" action, but warned that "the scientific community needs better mechanisms to identify and retract fraudulent papers."
"This is completely in alignment with what we were calling them out for at the time," Lynn Goldman, a pediatrician and epidemiologist at GWU who co-signed the 2002 letter, added to AFP.
- Polo shirts -
Two of the paper's three original authors have since died, while first author Gary Williams, a professor at New York Medical College, did not respond to AFP's request for comment.
Monsanto maintains it acted appropriately, and that its product is safe. "Monsanto's involvement with the Williams et al paper did not rise to the level of authorship and was appropriately disclosed in the acknowledgments."
The company declined to comment on internal emails that suggested otherwise, including one in which a Monsanto scientist asked a colleague whether "the team of people" who worked on the Williams paper and another study "could receive Roundup polo shorts as a token of appreciation for a job well done."
Glyphosate was brought to market as a herbicide in the 1970s and initially welcomed as less toxic than DDT.
But its soaring use -- especially after Monsanto introduced glyphosate-tolerant seeds that allowed it to be sprayed widely over crops -- drew increasing scrutiny in the 1990s, making the 2000 paper hugely influential.
According to Oreskes's research, it was cited as supporting evidence for glyphosate's safety by groups ranging from the Canadian Forest Service to the International Court of Justice, the US Congress and the European Parliamentary Research Service.
- Legal interest -
In 2015, the World Health Organization's International Agency for Research on Cancer classified glyphosate as "probably carcinogenic to humans."
Several countries have since moved to restrict or ban its use, including France, which has prohibited household applications. Bayer, which acquired Monsanto, said it would phase out Roundup for US residential use in 2023 in response to growing lawsuits.
Nathan Donley, a scientist with the Center for Biological Diversity, told AFP he does not expect the retraction to sway the US Environmental Protection Agency, now under the pro-agricultural-industry Donald Trump administration, which has thrown its weight behind Bayer in an ongoing Supreme Court case.
But "it could play a role in litigation that is moving forward in the US against the EPA's proposed decision to renew glyphosate," Donley told AFP, adding that European regulators might also take note.
For Donley and others, the deeper concern is that the case may be far from unique.
"I am sure there (are a) lot (of) such ghost-written and undeclared conflict papers in the literature, but they are very difficult to unearth unless one goes really deep in litigation cases," John Ioannidis, a Stanford University professor who founded the field of meta-research told AFP.
M.Vogt--VB